Transplant Statistics: Annual Report

Organ Type		Year of Transplant
		1991	1992	1993	1994	1995	1996	1997	1998	1999	2000
Total	Total Recipients	15,751	16,131	17,641	18,308	19,365	19,718	20,277	21,442	21,762	22,965
	# With PTLD (1)	189	202	206	200	231	217	202	127	93	33
	% With PTLD (1)	1.2%	1.3%	1.2%	1.1%	1.2%	1.1%	1.0%	0.6%	0.4%	0.1%
Kidney	Total Recipients	9,674	9,736	10,361	10,645	11,051	11,361	11,673	12,376	12,548	13,371
	# With PTLD (1)	61	61	57	58	75	57	74	52	38	15
	% With PTLD (1)	0.6%	0.6%	0.6%	0.5%	0.7%	0.5%	0.6%	0.4%	0.3%	0.1%
Pancreas	Total Recipients	78	64	113	94	107	165	208	246	361	436
	# With PTLD (1)	-	1	3	1	1	2	-	2	-	-
	% With PTLD (1)	-	1.6%	2.7%	1.1%	0.9%	1.2%	-	0.8%	-	-
Kidney-Pancreas	Total Recipients	452	493	661	748	918	860	852	971	934	911
	# With PTLD (1)	5	4	4	5	4	12	13	-	3	-
	% With PTLD (1)	1.1%	0.8%	0.6%	0.7%	0.4%	1.4%	1.5%	-	0.3%	-
Liver	Total Recipients	2,953	3,064	3,440	3,652	3,924	4,072	4,176	4,503	4,708	4,954
	# With PTLD (1)	21	30	31	38	41	57	54	31	27	11
	% With PTLD (1)	0.7%	1.0%	0.9%	1.0%	1.0%	1.4%	1.3%	0.7%	0.6%	0.2%
Intestine	Total Recipients	12	22	34	23	45	45	68	69	71	79
	# With PTLD (1)	1	3	2	-	2	3	6	1	1	1
	% With PTLD (1)	8.3%	13.6%	5.9%	-	4.4%	6.7%	8.8%	1.4%	1.4%	1.3%
Heart	Total Recipients	2,126	2,169	2,298	2,339	2,359	2,343	2,295	2,345	2,181	2,198
	# With PTLD (1)	91	84	80	75	70	49	30	20	12	2
	% With PTLD (1)	4.3%	3.9%	3.5%	3.2%	3.0%	2.1%	1.3%	0.9%	0.6%	0.1%
Lung	Total Recipients	405	535	674	736	892	832	945	887	910	968
	# With PTLD (1)	9	19	26	22	31	34	21	20	11	3
	% With PTLD (1)	2.2%	3.6%	3.9%	3.0%	3.5%	4.1%	2.2%	2.3%	1.2%	0.3%
Heart-Lung	Total Recipients	51	48	60	71	69	40	60	45	49	48
	# With PTLD (1)	1	-	3	1	7	3	4	1	1	1
	% With PTLD (1)	2.0%	-	5.0%	1.4%	10.1%	7.5%	6.7%	2.2%	2.0%	2.1%

Source: OPTN/SRTR Data as of August 1, 2001.

(-) = None in category.

(1) PTLD: Posttransplant Lymphoproliferative Disorders.

Year indicates the year of transplant, not the year of cancer diagnosis.

Includes both cadaveric and living donor transplants.

Percent decreases in later years because of limited follow-up.